Department of Medicine, Division of Hematology/Oncology, University of Alabama at Birmingham, Birmingham, AL; and.
Department of Medicine, Division of Hematology, University of North Carolina School of Medicine, Chapel Hill, NC.
Blood. 2020 Sep 24;136(13):1487-1498. doi: 10.1182/blood.2019000820.
Most arterial thrombotic events have a clear atherosclerotic or cardioembolic etiology, but hematologists are frequently asked to assist in the diagnosis and management of a patient with a nonatherosclerotic and noncardioembolic arterial event, referred to here as an unexplained arterial thrombosis. Because there is an assorted list of factors that can precipitate an arterial event, we present a systematic diagnostic approach to ensure consideration of not only primary hypercoagulable disorders, but also pro-thrombotic medications or substances, vascular and anatomic abnormalities, and undiagnosed systemic disorders, such as malignancy and autoimmune diseases. We also review existing literature of the role of hypercoagulable disorders in arterial thrombosis and discuss our approach to thrombophilia workup in patients after an unexplained arterial event. We conclude with 3 representative cases to both illustrate the application of the outlined diagnostic schema and discuss common management considerations, specifically the selection of anticoagulation vs antiplatelet therapy for secondary prevention.
大多数动脉血栓事件都有明确的动脉粥样硬化或心源性栓塞病因,但血液科医生经常被要求协助诊断和治疗非动脉粥样硬化和非心源性栓塞性动脉事件,这里称为不明原因的动脉血栓形成。由于有一系列可能引发动脉事件的因素,我们提出了一种系统的诊断方法,不仅要考虑原发性高凝状态疾病,还要考虑促血栓形成的药物或物质、血管和解剖异常以及未确诊的系统性疾病,如恶性肿瘤和自身免疫性疾病。我们还回顾了高凝状态疾病在动脉血栓形成中的作用的现有文献,并讨论了我们在不明原因的动脉事件后对血栓形成倾向进行检查的方法。最后,我们通过 3 个有代表性的病例来说明所概述的诊断方案的应用,并讨论常见的治疗考虑因素,特别是抗凝治疗与抗血小板治疗在二级预防中的选择。